Trial Search Results
Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing
FLIP topography has been FDA cleared to evaluate a variety of esophageal conditions, but has never been evaluated in patients with scleroderma. The investigators hope to evaluate this technology in patients who have scleroderma and various esophageal symptoms, and compare to non-scleroderma patients.
Stanford is currently not accepting patients for this trial.
- Device: FLIP topography
- Procedure: Upper Endoscopy
- Must have a clinical indication for upper endoscopy (recruiting patients both with
scleroderma and without)
- not healthy enough to undergo an upper endoscopy
- mass, stricture, ring, or web present on upper endoscopy
- history of esophageal cancer
- history of esophageal surgery
Ages Eligible for Study
18 Years - 90 Years
Genders Eligible for Study